FIELD: medicine, psychiatry.
SUBSTANCE: it is necessary to fill in the questionnaire that contains objective and subjective values that characterize a patient's quality of life and social functioning. While evaluating a patient's state it is important to take into account a patient's critical attitude to his own psychic state, critical attitude to environment, both objective and subjective values on social functioning, financial-household sphere, the state of health, as a whole. It is necessary to calculate the generalization coefficient (GC) that takes into account the value of social functioning (SF) and that of quality of life (QL) by the following formula: GC=(QL+SF)/2. Also, it is important to calculate the dissociation coefficient (DC) among objective and subjective values by the following formula: DC=QL/QL and ratio of sf/ql. At GC value ranged 1.0-0.86 and DC being 1.14-0.85 and, also, at GC ranged 0.86-0.81 and DC being 1.14-0.85 one should detect the absence of psychic disorders and diseases. At GC ranged 0.86-0.81 and DC ranged 1.14-1.17 and 0.77-0.85 it is necessary to reveal the patients for whom the risk for the development of psychic disorders is rather low. At SF/QL ratio being below 1 in such patients, the leading causes affecting their state is being the decrease of financial level and disease of somatic nature. At GC ranged 0.81-0.71 and DC being 1.17-0.77 it is possible to diagnose the presence of disorders of boundary level and the causes to maintain the state in these groups of sick patients at SF/QL ratio being equal to 1 has been the combination of somatic diseases along with psychic pathology. At GC ranged 0.61-0.49 and DC being 2.34-0.64 and, also, at values GC being equal to 0.49-0.39 and any DC values one should diagnose the presence of severe forms of boundary disorders and if SF/QL ratio is above 1 the leading impact upon their state had been made by psychic pathology, and the decrease of social functioning and critical evaluation of one's state is the result of psychic pathology. The innovation enables to detect the reasons that affect mainly a patient's state in every group under investigation.
EFFECT: higher accuracy of evaluation.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING LIFE QUALITY FOR DIAGNOSING HUMAN MENTAL CONDITION | 2004 |
|
RU2261045C1 |
METHOD FOR DETECTING RISK GROUPS OF MENTAL DISORDERS RELATED TO WORKING PROCESS INTENSITY | 2009 |
|
RU2412645C1 |
DIAGNOSTIC TECHNIQUE FOR QUALITY OF LIFE OF PATIENTS SUFFERING GENITAL INFECTIONS | 2011 |
|
RU2469320C1 |
METHOD FOR OBJECTIVIZATION OF ESTIMATING QUALITY OF LIFE IN PATIENTS WITH PSYCHOSOMATIC DISEASES | 2005 |
|
RU2295287C2 |
METHOD FOR EVALUATING EFFICIENCY OF COMBINED PHARMACO- AND PSYCHOTHERAPY IN PATIENTS WITH NEUROPSYCHIC DISORDERS | 2002 |
|
RU2221486C1 |
METHOD OF DIAGNOSTICS OF NEUROLOGIC PATIENTS WITH CEREBROVASCULAR PATHOLOGY | 2005 |
|
RU2341190C2 |
METHOD OF QUANTITATIVE ASSESSMENT OF PARAMETERS OF LIFE QUALITY OF MENTALLY ILL PEOPLE | 2010 |
|
RU2452378C2 |
METHOD OF TREATING PATIENTS WITH CHRONIC INSOMNIA | 2023 |
|
RU2809693C1 |
METHOD FOR VISION DISORDER DEGREE DETERMINATION IN CASE OF VITREORETINAL DISEASES | 2016 |
|
RU2634009C1 |
METHOD OF TREATING PATIENTS WITH CHRONIC INSOMNIA | 2019 |
|
RU2714296C1 |
Authors
Dates
2007-06-10—Published
2006-06-19—Filed